Induction ICI Combination Followed by CRT Is An Effective Bladder-Sparing Treatment in Patients with MIBC and Response Can Be Monitored by ctDNA By Ogkologos - March 12, 2026 266 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the INDIBLADE study Source RELATED ARTICLESMORE FROM AUTHOR ESMO Announces 2026 Society Award Recipients Honouring Excellence in Cancer Research, Care and Leadership Adjuvant Olaparib Continues to Improve Multiple Outcomes in Patients with Germline BRCA1/2-associated High-Risk HER2-negative EBC EMA Recommends Refusing the Marketing Authorisation for Copper (64Cu) Oxodotreotide MOST POPULAR A tribute to Professor Anne Charlton June 23, 2020 Study Offers Insights on Health Problems among AYA Cancer Survivors August 7, 2020 FDA Grants Accelerated Approval to Sotorasib for KRAS G12C-mutated NSCLC June 4, 2021 Clinical Benefit of Pembrolizumab in Patients with Previously Treated Advanced Clear... March 4, 2025 Load more HOT NEWS Professor Ian Tomlinson: “Philanthropy is priceless to science” Large DFS Benefit from Adjuvant Cemiplimab Among Patients at High Risk... ESMO Welcomes Launch of Health Package Introducing EU Measures That Can... Similar Efficacy Between Subcutaneous and Intravenous Pembrolizumab Given with Chemotherapy for...
